发明名称 |
RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA) |
摘要 |
The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of HBV gene expression and/or activity, and/or modulate a HBV gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against HBV gene expression. |
申请公布号 |
US9029341(B2) |
申请公布日期 |
2015.05.12 |
申请号 |
US201113817152 |
申请日期 |
2011.08.12 |
申请人 |
Sirna Therapeutics, Inc. |
发明人 |
Bartz Steve;Brown Duncan;Robinson Michael |
分类号 |
C12N15/11;C12N15/113;A61K9/51 |
主分类号 |
C12N15/11 |
代理机构 |
McCarter & English, LLP |
代理人 |
McCarter & English, LLP ;Zacharakis Maria Laccotripe;Nagle Deborah L. |
主权项 |
1. A double-stranded short interfering nucleic acid (siNA) molecule that inhibits expression of the Hepatitis B virus (HBV), comprising a sense strand comprising the nucleotide sequence 5′-uuCCgcagUauGGaUCGGCUsU-3′ (SEQ ID NO:376) and an antisense strand comprising the nucleotide sequence 5′-B GccGAuccAuAcuGcGGAAUsU B-3′ (SEQ ID NO:224),
wherein B is an inverted a basic moiety; the bolded nucleotides comprise 2′-O-methyl modifications, the lower case nucleotides comprise 2′-fluoro modifications, and the s is a phosphorothioate linkage. |
地址 |
Cambridge MA US |